This was confirmed by in vitro studies, where in both human pulmonary microvascular endothelial cells (HPMECs) and lung epithelial A549 cells, JCAD knockdown prevented a wide range of inflammatory gene expressions, implicating JCAD in COPD development. Here, JCAD is linked to chronic obstructive pulmonary disease.